In this issue:
Treatment-free remission after second-line nilotinib in CML-CP
Genetics and pathogenesis of DLBCL
Sorafenib in FLT3-ITD AML undergoing alloHSCT
MHC class II and PDL-1 expression predict outcome in HL
IKZF1plus defines a poor prognostic profile in paediatric ALL
Umbralisib in R/R CLL and lymphoma
Gene-expression profiling score predicts follicular lymphoma outcome
Up-front ASCT in PTCL for patients in response after induction
Reduced-intensity vs myeloablative conditioning in AML in first CR
Rituximab plus bendamustine or chlorambucil for CLL
Please login below to download this issue (PDF)